Recherche
-
Subcellular specificity of cannabinoid effects in striatonigral circuits
(Neuron. vol. 109, n° 9, pp. 1513-1526.e11, 2021-05-05)Article de revueLibre accès -
Communication and social interaction in the cannabinoid-type 1 receptor null mouse: Implications for autism spectrum disorder
(Autism Research. vol. 14, n° 9, pp. 1854-1872, 2021-09)Article de revueLibre accès -
Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts
(CNS drugs. vol. 35, n° 11, pp. 1217-1232, 2021-11)Article de revue -
Determinants of therapeutic lag in multiple sclerosis
(Multiple Sclerosis Journal. vol. 27, n° 12, pp. 1838-1851, 2021-10)Article de revueLibre accès -
Olfaction and anosmia: From ancient times to COVID-19
(Journal of the Neurological Sciences. vol. 425, 2021-06-15)Article de revueLibre accès -
Validation of the French version of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS)
(Multiple Sclerosis and Related Disorders. vol. 48, 2021-02)Article de revueLibre accès -
Identification of BiP as a CB1 receptor-interacting protein that fine-tunes cannabinoid signaling in the mouse brain
(Journal of Neuroscience. vol. 41, n° 38, pp. 7924-7941, 2021-09-22)Article de revueLibre accès -
New perspectives on the role of the neurosteroid pregnenolone as an endogenous regulator of type-1 cannabinoid receptor (CB1R) activity and function
(Journal of Neuroendocrinology. vol. 34, n° 2, 2022-02)Article de revueLibre accès